Accreditations & Approvals Venus Remedies Expands Footprint in Latin America Venus Remedies has secured its first marketing authorization in Argentina for Ceftriaxone, strengthening its footprint in Latin America.
Publications Mr. Saransh Chaudhary featured in IndiaMed Today Mr. Saransh Chaudhary, Executive Director and CEO of VMRC, was featured in IndiaMed Today for his insights on antimicrobial resistance.
Accreditations & Approvals Venus Remedies Receives Saudi FDA Approval for Plerixafor Venus Remedies has received Saudi FDA approval for Plerixafor, marking its first global authorization for the specialty oncology drug.
News A New Chapter in Leadership: Strategic Appointments to Drive Growth and Innovation at Venus Remedies Venus Remedies enters a new chapter of leadership with the appointment of Mr. Saransh Chaudhary as Executive Director and Dr. Gurminder Singh Bedi as Non-Executive Independent Director.
Events An Evening of Celebration: PPL Season 10 at Venus Venus Remedies celebrated PPL Season 10 on the evening of the Respected CMD Sir's birthday. The event honoured winning teams with trophies, cash prizes, and certificates while celebrating teamwork and the company’s culture.
Events Honouring the Respected CMD Sir’s Vision Through Education Support on His Birthday Venus Remedies celebrated the birthday of the Respected CMD sir, Mr Pawan Chaudhary, with children’s activities, performances, and an Education Grant. It reflected our commitment to supporting students in their educational journey.
News Venus Remedies Secures 10 New Market Authorizations Venus Remedies secures 10 new Market Authorizations across key global markets, strengthening access to injectable therapies in oncology, anti-infectives, critical care, and anticoagulation.
News Venus Remedies Recognized among the Top 10 Injectable Manufacturer Companies in India Venus Remedies has been recognized among the Top 10 Injectable Manufacturers in India, reflecting its long-standing focus on quality, safety, and complex injectable therapies.
Events Venus Celebrates Financial Independence With Mission 2030 With the commitment to build a stronger future for stakeholders and patients worldwide, Venus Remedies begins a new chapter.
Associations Venus’ Participation in the IAIH Panel Discussion Venus Remedies joined the IAIH panel discussion at the India AMR Innovation Workshop, highlighting the need to move AMR innovations from research to real-world impact.
Events Marking 35 Years of Growth and Commitment in Healthcare Reflecting on our journey of quality healthcare on the occasion of 35th Annual Raising Day.
Accreditations & Approvals Expanding Global Access: New Market Authorizations for Venus Remedies Venus Remedies expands global healthcare access with new market authorizations in essential care
Accreditations & Approvals Strengthening Global Reach: Venus Remedies Unit I & II Approved by the Gabon Authority Venus Remedies receives Gabon Authority approval for Panchkula and Baddi units, expanding global reach with GMP-compliant manufacturing excellence.
Engagements Venus Remedies Reinforces Global Vision at World Health Expo Dubai 2026 Venus Remedies showcased its global healthcare vision at the World Health Expo Dubai 2026.
News How Union Budget 2026 - 27 Accelerates Research-Led Pharmaceutical Growth: Insights by Mr Saransh Chaudhary Saransh Chaudhary highlights how India’s Union Budget 2026–27 marks a decisive shift toward science-driven pharma growth and stronger healthcare foundations.
Bulletin PLI Milestone: Venus Remedies Secures Incentive for FY 2024 - 25 Securing 75% of the eligible FY 2024–25 PLI incentive, Venus Remedies reaffirms its manufacturing excellence, consistent performance, and commitment to strengthening India’s pharmaceutical ecosystem
Mr. Saransh Chaudhary on CDSCO's Safe Pharma Labelling CDSCO’s new labelling reforms mark a smart step toward safer medicines, clearer packaging, and stronger global trust in Indian pharma. This feature highlights its importance
Venus Remedies Secures New Market Authorizations We are proud to share that Venus Remedies received new marketing authorizations, including a significant regulatory accomplishment in Indonesia for its antibiotic combination, Ceftazidime + Avibactam. This marks Venus Remedies’ entry in the anti-infective segment in Indonesia, and the product will become the first generic version of Ceftazidime + Avibactam launched. It
KBC 2026 Launch: O&M Highlights at Venus Remedies The new year started with a grand Officers & Management Meet at Venus Remedies. Our esteemed leadership and the HODs came together to reflect on the achievements of 2025, set goals for 2026, and celebrate the winners of the KBC 2025 championship. The event was made extra special by the
Welcoming the New Year 2026 at Venus Remedies The New Year at Venus Remedies was welcomed with a sense of optimism, reflection, and shared purpose. As teams across the organisation came together to mark the first day of the year, the focus remained on setting the right tone for the months ahead. The occasion was not just about
Glimpses of 2025: A Year of Progress at Venus Remedies 2025 was a year of steady progress at Venus Remedies—shaped by collaboration, responsibility, and a continued focus on quality across teams and locations. From global platforms to internal initiatives and community programs, the year reflected how progress is built through people working together with purpose. Recognition That Motivated Us
Graduation Ceremony 2025: Celebrating Learning at Venus Progress is rarely instant. It grows through steady effort, learning on the job, and the discipline to improve every day. At Venus Remedies, we believe that continuous upskilling is essential to staying relevant and capable in a fast-evolving industry. Learning here is not treated as a one-time achievement. It is
Bulletin World Antimicrobial Awareness Week 2025 at Venus Remedies Every year, the world comes together from 18-24 November to observe World Antimicrobial Awareness Week—a global movement dedicated to understanding antimicrobial resistance (AMR) and encouraging the responsible use of antibiotics. At Venus Remedies Ltd., this week is more than an observance. It is a reminder of the responsibility we
Venus Remedies Featured in Hindustan Times on AMR We are delighted to share an important milestone for all of us at Venus Remedies. An article written by Saransh Chaudhary, President – Global Critical Care & CEO – Venus Medicine Research Centre, has been featured in the Hindustan Times, one of India’s most trusted news platforms. This recognition highlights our
New Global Drug Approvals Expand Venus Remedies Reach November 2025 has been a special month for us at Venus Remedies. We are proud to share that we have received several new Marketing Authorizations across important global markets. Each approval brings us one step closer to our goal of making advanced oncology and critical care medicines accessible to more
